How we forecast tomorrow's haemovigilance.

Area of Science:

• Medicine
• Public Health
• Biotechnology

Background:

• Haemovigilance, the surveillance of blood product safety, has over 40 years of international experience.
• Continuous development is essential to adapt to evolving healthcare landscapes and transfusion practices.

Purpose of the Study:

• To review the global scope and activities of current haemovigilance systems.
• To explore preparedness for new blood products and alternative therapies.
• To examine advancements in data acquisition and analysis for haemovigilance.

Main Methods:

• Literature review of international haemovigilance practices.
• Analysis of emerging trends in transfusion medicine and data technology.
• Exploration of future challenges and opportunities in blood product safety.

Main Results:

• Haemovigilance systems are expanding globally with diverse activities.
• Preparation for novel blood products and transfusion alternatives is a key focus.
• New data acquisition tools, including patient-reported outcomes and wearable technology, are being integrated.

Conclusions:

• Haemovigilance must adapt to incorporate new technologies and therapies.
• Enhanced data analysis and communication are crucial for effective blood product safety.
• International collaboration remains vital for advancing global haemovigilance efforts.